{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T07:01:44Z","timestamp":1791270104708,"version":"4.1.0"},"publisher-location":"Vienna","reference-count":22,"publisher":"Springer Vienna","isbn-type":[{"value":"9783211289273","type":"print"},{"value":"9783211452950","type":"electronic"}],"license":[{"start":{"date-parts":[[2006,1,1]],"date-time":"2006-01-01T00:00:00Z","timestamp":1136073600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2006]]},"DOI":"10.1007\/978-3-211-45295-0_57","type":"book-chapter","created":{"date-parts":[[2006,11,22]],"date-time":"2006-11-22T13:23:35Z","timestamp":1164201815000},"page":"373-381","source":"Crossref","is-referenced-by-count":190,"title":["Role of cytokines in inflammatory process in Parkinson\u2019s disease"],"prefix":"10.1007","author":[{"given":"M.","family":"Sawada","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Imamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Nagatsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"issue":"Suppl","key":"57_CR1","first-page":"31","volume":"56","author":"P. Foley","year":"1999","unstructured":"Foley P, Riederer P (1999) Pathogenesis and preclinical course of Parkinson\u2019s disease. J Neural Transm [Suppl] 56: 31\u201374","journal-title":"J Neural Transm"},{"key":"57_CR2","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.expneurol.2005.01.013","volume":"193","author":"A. Hald","year":"2005","unstructured":"Hald A, Lotharius J (2005) Oxidative stress and inflammation in Parkinson\u2019s disease: is there a causal link? Exp Neurol 193: 279\u2013290","journal-title":"Exp Neurol"},{"key":"57_CR3","doi-asserted-by":"publisher","first-page":"2875","DOI":"10.1073\/pnas.040556597","volume":"97","author":"A. Hartmann","year":"2000","unstructured":"Hartmann A, Hunot S, Michel PP, Muriel MP, Vyas S, Faucheux BA, Mouatt-Prigent A, Turmel H, Srinivasan A, Ruberg M, Evans GI, Agid Y, Hirsch EC (2000) Caspase-3: a vulnerability factor and a final effector in the apoptotic cell death of dopaminergic neurons in Parkinson\u2019s disease. Proc Natl Acad Sci USA 97: 2875\u20132880","journal-title":"Proc Natl Acad Sci USA"},{"issue":"Suppl","key":"57_CR4","doi-asserted-by":"crossref","first-page":"S115","DOI":"10.1002\/ana.410440717","volume":"44","author":"E.C. Hirsch","year":"1998","unstructured":"Hirsch EC, Hunot S, Damier P, Faucheux B (1998) Glial cells and inflammation in Parkinson\u2019s disease: a role in neurodegeneration? Ann Neurol 44(Suppl): S115\u2013S120","journal-title":"Ann Neurol"},{"key":"57_CR5","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1002\/1531-8257(199903)14:2<383::AID-MDS1037>3.0.CO;2-F","volume":"14","author":"E.C. Hirsch","year":"1999","unstructured":"Hirsch EC, Hunot S, Faucheux B, Agid Y, Mizuno Y, Mochizuki WG, Tatton N, Olanow WC (1999) Dopaminergic neurons degenerate by apoptosis in Parkinson\u2019s disease. Mov Disord 14: 383\u2013385","journal-title":"Mov Disord"},{"key":"57_CR6","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/978-0-306-47593-1_43","volume-title":"Mapping the progress of Alzheimer\u2019s and Parkinson\u2019s disease","author":"E.C. Hirsch","year":"2002","unstructured":"Hirsch EC (2002) Inflammatory changes in Parkinson\u2019s disease. In: Mizuno Y, Fischer A, Hanin I (eds) Mapping the progress of Alzheimer\u2019s and Parkinson\u2019s disease. Kluwer Akademic\/Plenum Publishers, New York, pp 259\u2013263"},{"key":"57_CR7","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1007\/s00401-003-0766-2","volume":"106","author":"K. Imamura","year":"2003","unstructured":"Imamura K, Hishikawa N, Sawada M, Nagatsu T, Yoshida M, Hashizume Y (2003) Distribution of major histocompatibility complex class II-positive microglia and cytokine profile of Parkinson\u2019s disease brains. Acta Neuropathol 106: 518\u2013526","journal-title":"Acta Neuropathol"},{"key":"57_CR8","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/s00401-004-0919-y","volume":"109","author":"K. Imamura","year":"2005","unstructured":"Imamura K, Hishikawa N, Ono K, Suzuki H, Sawada M, Nagatsu T, Yoshida M, Hashizume Y (2005) Cytokine production of activated microglia and decrease in neurotrophic factors of neurons in the hippocampus of Lewy body disease brains. Acta Neuropathol 109: 141\u2013150","journal-title":"Acta Neuropathol"},{"key":"57_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s007020050001","volume":"107","author":"K.A. Jellinger","year":"2000","unstructured":"Jellinger KA (2000) Cell death machanism in Parkinson\u2019s disease. J Neural Transm 107: 1\u201329","journal-title":"J Neural Transm"},{"issue":"Suppl","key":"57_CR10","first-page":"73","volume":"20","author":"K. Kosaka","year":"2002","unstructured":"Kosaka K (2002) Lewy body disease. Neuropathol 20(Suppl): 73\u201378","journal-title":"Neuropathol"},{"key":"57_CR11","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1212\/WNL.38.8.1285","volume":"38","author":"P.L. McGeer","year":"1988","unstructured":"McGeer PL, Itagaki S, Boyes BE, McGeer EG (1988) Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson\u2019s disease and Alzheimer\u2019s disease brain. Neurology 38: 1285\u20131291","journal-title":"Neurology"},{"key":"57_CR12","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/0165-0173(95)00011-9","volume":"21","author":"P.L. McGeer","year":"1995","unstructured":"McGeer PL, McGeer EG (1995) The inflammatory response system of brain: implications for therapy of Alzheimer\u2019s and other neurodegenerative diseases. Brain Res Rev 21: 195\u2013218","journal-title":"Brain Res Rev"},{"key":"57_CR13","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/S0306-4522(99)00455-8","volume":"95","author":"B. Mirza","year":"2000","unstructured":"Mirza B, Hadberg H, Thomsen P, Moos T (2000) The absence of reactive astrocytosis is indicative of a unique inflammation process in Parkinson\u2019s disease. Neuroscience 95: 425\u2013432","journal-title":"Neuroscience"},{"issue":"Suppl 2","key":"57_CR14","first-page":"54","volume":"11","author":"Y. Mizuno","year":"2005","unstructured":"Mizuno Y (2005) Progress in familial Parkinson\u2019s disease. Parkinsonism and Related Disorders 11(Suppl 2): 54\u201354 (Abstract, 16th International Congress on Parkinson\u2019s Disease and Related Disorders, Berlin, June 5\u20139, 2005)","journal-title":"Parkinsonism and Related Disorders"},{"key":"57_CR15","first-page":"135","volume":"80","author":"M. Mogi","year":"2000","unstructured":"Mogi M, Nagatsu T (2000) Neurotrophins and cytokines in Parkinson\u2019s disease. Adv Neurol 80: 135\u2013139","journal-title":"Adv Neurol"},{"key":"57_CR16","first-page":"88","volume":"2","author":"T. Nagatsu","year":"1999","unstructured":"Nagatsu T, Mogi M, Ichinose H, Togari A, Riederer P (1999) Cytokines in Parkinson\u2019s disease. Neuro Sci News 2: 88\u201390","journal-title":"Neuro Sci News"},{"key":"57_CR17","first-page":"143","volume":"Suppl 58","author":"T. Nagatsu","year":"2000","unstructured":"Nagatsu T, Mogi M, Ichinose H, Togari A (2000) Cytokines in Parkinson\u2019s disease. J Neural Transm [Suppl 58]: 143\u2013151","journal-title":"J Neural Transm"},{"key":"57_CR18","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1007\/s007020200061","volume":"109","author":"T. Nagatsu","year":"2002","unstructured":"Nagatsu T (2002) Parkinson\u2019s disease: changes in apoptosis-related factors suggesting possible gene therapy. J Neural Transm 109: 731\u2013745","journal-title":"J Neural Transm"},{"key":"57_CR19","doi-asserted-by":"publisher","first-page":"999","DOI":"10.2174\/1381612053381620","volume":"11","author":"T. Nagatsu","year":"2005","unstructured":"Nagatsu T, Sawada M (2005) Inflammatory process in Parkinson\u2019s disease: role for cytokines. Curr Pharmac Design 11: 999\u20131016","journal-title":"Curr Pharmac Design"},{"key":"57_CR20","first-page":"910","volume":"7","author":"A.M. Sarder","year":"1996","unstructured":"Sarder AM, Czudek C, Reynolds GP (1996) Dopamine deficits in the brain: the neurochemical basis of parkinsonian symptoms in AIDS. Neuro Report 7: 910\u2013912","journal-title":"Neuro Report"},{"key":"57_CR21","doi-asserted-by":"publisher","first-page":"42136","DOI":"10.1074\/jbc.M200862200","volume":"277","author":"F. Vilhardt","year":"2002","unstructured":"Vilhardt F, Plastre O, Sawada M, Suzuki K, Wiznerowicz M, Kiyokawa E, Trono D, Krause K-H (2002) The HIV-1 Nef protein and phagocyte NADPH oxidase activation. J Biol Chem 277: 42136\u201342143","journal-title":"J Biol Chem"},{"key":"57_CR22","unstructured":"Youdim MBH, Riederer P (1997) Understanding Parkinson\u2019s disease. Sci Am: 82\u201389"}],"container-title":["Parkinson\u2019s Disease and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-211-45295-0_57","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,16]],"date-time":"2019-05-16T04:07:58Z","timestamp":1557979678000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-3-211-45295-0_57"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006]]},"ISBN":["9783211289273","9783211452950"],"references-count":22,"URL":"https:\/\/doi.org\/10.1007\/978-3-211-45295-0_57","relation":{},"subject":[],"published":{"date-parts":[[2006]]}}}